Internal Medicine, Endocrinology, Diabetes, & Metabolism · Santa Maria, CA
NPI
1750318127
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
1300 E Cypress St Ste C2
Santa Maria, CA, 93454
Phone (805) 349-8972
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.4M
12,249 services
Medicare patients, 2024
1,190
Average age 75
Drug cost, 2024
$5.7M
9,290 prescriptions
Company payments, 2025
$3,731
From 28 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michael K Lai was code 99215 (office e&m - established), 1,390 times for 960 patients. In total Michael K Lai billed 12,249 services in 24 codes, and Medicare paid $1.4M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-10-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 1,390 | 960 | $121.98 | $170K |
| 99214 Office E&M - Established | Office | 1,239 | 592 | $89.84 | $111K |
| 99458 E&M - Miscellaneous | Office | 1,008 | 219 | $29.78 | $30K |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 958 | 231 | $36.47 | $35K |
| 95251 Test - Miscellaneous | Office | 592 | 231 | $24.12 | $14K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 551 | 248 | $47.18 | $26K |
| 99457 E&M - Miscellaneous | Office | 490 | 243 | $37.66 | $18K |
| 99454 E&M - Miscellaneous | Office | 338 | 180 | $38.91 | $13K |
| 99453 E&M - Miscellaneous | Office | 201 | 194 | $16.21 | $3,258 |
| 99205 Office E&M - New | Office | 155 | 155 | $153.55 | $24K |
| 95250 Test - Miscellaneous | Office | 23 | 22 | $121.33 | $2,791 |
| 91200 Standard X-ray | Office | 20 | 18 | $24.30 | $486 |
| 76536 Ultrasound - Nonspecific | Office | 15 | 15 | $80.17 | $1,203 |
By year: 2022 $261K for 2,722 services; 2023 $434K for 3,476 services; 2024 $1.4M for 12,249 services.
Medicare prescription drug claims, 2024
In 2024, the drug Michael K Lai prescribed most often to Medicare patients was Ozempic (Semaglutide), with 953 prescriptions and refills. In total Michael K Lai wrote 9,290 Medicare prescriptions that cost $5.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ozempic Semaglutide | 953 | 1,662 | 190 | $1.6M |
| Pioglitazone Hcl Generic | 573 | 1,501 | 153 | $9,200 |
| Atorvastatin Calcium Generic | 465 | 1,350 | 145 | $4,956 |
| Levothyroxine Sodium Generic | 436 | 1,183 | 122 | $6,558 |
| Synthroid Levothyroxine Sodium | 412 | 1,118 | 116 | $48K |
| Synjardy Xr Empagliflozin/Metformin Hcl | 393 | 814 | 89 | $430K |
| Ezetimibe Generic | 308 | 915 | 100 | $8,500 |
| Losartan Potassium Generic | 260 | 744 | 74 | $2,854 |
| Rosuvastatin Calcium Generic | 232 | 647 | 67 | $4,257 |
| Xigduo Xr Dapaglifloz Propaned/Metformin | 216 | 482 | 53 | $258K |
| Alendronate Sodium Generic | 202 | 528 | 57 | $2,072 |
| Jardiance Empagliflozin | 200 | 375 | 45 | $211K |
| Farxiga Dapagliflozin Propanediol | 196 | 411 | 48 | $219K |
| Trulicity Dulaglutide | 179 | 343 | 49 | $332K |
| Lisinopril Generic | 154 | 432 | 40 | $1,205 |
Brand drugs: 4,176 claims; generic drugs: 4,915 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Michael K Lai $3,731 ($3,731 in general payments such as food, travel and fees) from 28 companies. The largest payer was Novo Nordisk Inc with $766.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 23 | $766 |
| Amgen Inc. AMGN | 20 | $650 |
| AstraZeneca Pharmaceuticals LP AZN | 9 | $345 |
| Abbvie Inc. ABBV | 11 | $236 |
| Beta Bionics, Inc. BBNX | 8 | $206 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 18 | $171 |
| Lilly USA, LLC LLY | 8 | $162 |
| Radius Health, Inc. | 7 | $146 |
| Madrigal Pharmaceuticals MDGL | 2 | $142 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $134 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.